Transversus Abdominis Plane Block in Children Undergoing Open Pyeloplasty Surgery
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the effectiveness of transversus abdominis plane (TAP) block in reducing postoperative opioid requirements and pain after open pyeloplasty surgery in children.
| Condition | Intervention | Phase |
|---|---|---|
|
Anesthesia |
Procedure: Transversus Abdominis Plane Block Procedure: Standard Anesthesia |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Transversus Abdominis Plane Block in Children Undergoing Open Pyeloplasty Surgery |
- Requirement for morphine post-surgery. [ Time Frame: 24 hours ] [ Designated as safety issue: No ]The primary outcome measure will be the proportion of children in the treatment and control groups requiring a dose of morphine.
- Amount of morphine administered post-surgery [ Time Frame: 24 hours ] [ Designated as safety issue: No ]Patients will receive intravenous morphine 0.05 mg/kg if the FLACC is ≥ 3/10 (equivalent to mild-to-moderate pain). Morphine may be given at 10 minute intervals as per standard protocol until the FLACC score is < 3/10, or the child declines additional pain medicine when offered.
- Assessment of pain scores post-surgery [ Time Frame: 24 hours ] [ Designated as safety issue: No ]Pain scores will be assessed using the Faces-Legs-Activity-Cry-Consolibility (FLACC) scale for children ≤ 7 years old. Pain scores will be assessed at admission (time=0, 5, 10, 15, 30), and then every 15 minutes thereafter until discharge from PACU.
- Incidence of morphine-related side effects post-surgery [ Time Frame: 24 hours ] [ Designated as safety issue: No ]Side effects of morphine include nausea or vomiting, respiratory depression, pruritus, over-sedation and delayed transition to oral intake.
| Estimated Enrollment: | 84 |
| Study Start Date: | November 2010 |
| Estimated Study Completion Date: | November 2012 |
| Estimated Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Treatment Group |
Procedure: Transversus Abdominis Plane Block
A block needle will be advanced in a medial to lateral direction until the tip is visualized in the transversus abdominis plane. After negative aspiration 0.4 ml/kg of bupivacaine 0.25% with 1:200 000 epinephrine will be injected. The total dose of bupivacaine will not exceed 2 mg/kg and the total volume will not be more than 20 ml.
|
| Active Comparator: Control Group |
Procedure: Standard Anesthesia
Local field infiltration with bupivacaine 0.25% with 1:200 000 epinephrine 0.4 ml/kg before skin incision.
|
Detailed Description:
Primary open pyeloplasty is a common elective surgical procedure at The Hospital for Sick Children. All children are given fentanyl plus local anesthetic wound infiltration for intraoperative analgesia. A retrospective audit demonstrated that 63% of children required additional opioid treatment in the early recovery period following surgery. Concern exists regarding potential side effects of opioids including nausea or vomiting, respiratory depression, pruritus, over-sedation and delayed transition to oral intake. More importantly, children may under-report their pain or pain may not be recognized by medical staff leading to inadequate provision of analgesia. This suggests that the use of a regional technique, such as a TAP block, may benefit children undergoing open pyeloplasty.
The ultrasound guided TAP block introduces a local anaesthetic to the transversus abdominis plane which is one of three muscle layers in the abdominal wall. This results in a block of the nerves leading to the abdominal wall thereby reducing pain sensations.
Eligibility| Ages Eligible for Study: | 1 Month to 6 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) classification score 1-3
- age 1 month to 6 years inclusive
Exclusion Criteria:
- children undergoing an additional surgical procedure at an anatomical location not covered by a unilateral TAP block during the same anesthetic
- children in whom a TAP block is contraindicated, i.e. surgical scar or distorted anatomy at the site of injection
- postoperative admission to the intensive care unit
- children with a known allergy to bupivacaine
- children with a history of chronic abdominal pain requiring opioid analgesics
- children with known renal insufficiency
- children with known impaired hepatic function
- children with known impaired cardiac function
- children known hypersensitivity to sodium metabisulfite
Contacts and Locations| Contact: Carolyne Pehora | 416-813-7654 ext 2406 | carolyne.pehora@sickkids.ca |
| Canada, Ontario | |
| The Hospital for Sick Children | Recruiting |
| Toronto, Ontario, Canada, M5G 1X8 | |
| Contact: Carolyne Pehora 416 813 7654 ext 2406 carolyne.pehora@sickkids.ca | |
| Principal Investigator: Jason Hayes, MD | |
| Sub-Investigator: Johanne Lynch, MD | |
| Sub-Investigator: Clyde Matava, MD | |
| Sub-Investigator: Armando Lorenzo, MD | |
| Sub-Investigator: Gail Wong, MD | |
| Principal Investigator: | Jason Hayes, MD | The Hospital for Sick Children, Toronto Canada |
More Information
No publications provided
| Responsible Party: | Dr. Jason Hayes / Principal Investigator, The Hospital for Sick Children |
| ClinicalTrials.gov Identifier: | NCT01243593 History of Changes |
| Other Study ID Numbers: | 1000019942 |
| Study First Received: | November 17, 2010 |
| Last Updated: | November 17, 2010 |
| Health Authority: | Canada: Health Canada |
Keywords provided by The Hospital for Sick Children:
|
pediatrics anesthesia pyeloplasty Transversus Abdominis Plane Block Regional Anesthesia |
Additional relevant MeSH terms:
|
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs |
Pharmacologic Actions Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 19, 2013